Feb 3, 2015, Second Pharma obtains the first EU-CEP certification for our product Valsartan. It not only means Second Pharma’s Valsartan be approved to enter into European Union market, but also means it will promote the sales of Valsartan in other markets. From now on, Second Pharma becames one of the outstanding pharmaceutical companies in China, who have all of US-FDA, EU-CEP, and WHO Prequalification certificates for their main products.